MAPK3 and infection: In 27 individuals with available PBMC specimens from multiple time points drawn following study entry (200–800 days post-infection, all anti-retroviral-naive), we evaluated prevalence of the p-ERK1/2-refractory phenotype and activation state within the CD8+ T cell compartment over time.